Formuepleje Limittellus Net Assets
Formuepleje Limittellus net assets. Based on the latest financial reports, Formuepleje Limittellus (FPILIM) has net assets worth Dkr596.00K DKK (≈ $93.25K USD) as of December 2013. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr598.00K ≈ $93.56K USD) and total liabilities (Dkr2.00K ≈ $312.91 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Formuepleje Limittellus equity growth rate to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr596.00K |
| % of Total Assets | 99.67% |
| Annual Growth Rate | 4.74% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Net Assets of Formuepleje Limittellus (2013–2014)
Net assets of Formuepleje Limittellus from 2013 to 2014. This chart illustrates how Formuepleje Limittellus's net assets have evolved over time, based on quarterly financial data. See net asset quality index of Formuepleje Limittellus to measure how much of total assets are equity-financed.
Annual Net Assets for Formuepleje Limittellus (2013–2014)
The table below shows the annual net assets of Formuepleje Limittellus from 2013 to 2014. For live market cap and overall valuation, see Formuepleje Limittellus (FPILIM) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2014-06-30 | Dkr596.00K ≈ $93.25K |
+4.74% |
| 2013-06-30 | Dkr569.03K ≈ $89.03K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Formuepleje Limittellus's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 11.0% over the analyzed period, indicating profitable operations and earnings retention.
Formuepleje Limittellus Net Assets Breakdown (June 2014)
Formuepleje Limittellus net assets breakdown by equity component as of June 2014.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Dkr476.00K | 79.87% |
| Common Stock | Dkr88.00K | 14.77% |
| Other Comprehensive Income | Dkr32.00K | 5.37% |
| Total Equity | Dkr596.00K | 100.00% |
Formuepleje Limittellus Competitors by Market Cap
The table below lists competitors of Formuepleje Limittellus ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dynacor Gold Mines Inc.
TO:DNG
|
$156.25 Million |
|
Sangoma Technologies Corp
TO:STC
|
$156.30 Million |
|
Protalix Biotherapeutics Inc
NYSE MKT:PLX
|
$156.31 Million |
|
Rugvista Group AB
ST:RUG
|
$156.35 Million |
|
WEST RED LAKE GOLD MINES
F:UJ0
|
$156.18 Million |
|
Vivozon Healthcare Inc
KQ:082800
|
$156.18 Million |
|
EDAP TMS S.A.
NASDAQ:FOCL
|
$156.12 Million |
|
Chiang Mai Ram Medical Business Public Company Limited
BK:CMR
|
$156.08 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Formuepleje Limittellus's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2013 to 2014, total equity changed from 569,029 to 596,000, a change of 26,971 (4.7%).
- Net income of 115,236 contributed positively to equity growth.
- Other comprehensive income decreased equity by 19,907.
- Other factors decreased equity by 68,358.
Equity Change Factors (2013 to 2014)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Dkr115.24K | +19.33% |
| Other Comprehensive Income | Dkr-19.91K | -3.34% |
| Other Changes | Dkr-68.36K | -11.47% |
| Total Change | Dkr- | 4.74% |
Book Value vs Market Value Analysis
This analysis compares Formuepleje Limittellus's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.71x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.01x to 1.71x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-06-30 | Dkr147.90 | Dkr296.64 | x |
| 2014-06-30 | Dkr173.97 | Dkr296.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Formuepleje Limittellus utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 19.33%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 90.56%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 1.00x
- Recent ROE (19.33%) is above the historical average (19.00%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 18.67% | 91.15% | 0.20x | 1.00x | Dkr49.33K |
| 2014 | 19.33% | 90.56% | 0.21x | 1.00x | Dkr55.64K |
Industry Comparison
This section compares Formuepleje Limittellus's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.
About Formuepleje Limittellus
Formuepleje Limittellus is headquartered in Hellerup, Denmark.